Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

, EDIT

Editas Medicine

$36.46

1.31 (3.73%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Recommendations
Intellia Therapeutics, Editas Medicine, Crispr Therapeutics analyst commentary at Jefferies »

Study in Nature Biotech…

NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

EDIT

Editas Medicine

$36.46

1.31 (3.73%)

CRSP

Crispr Therapeutics

$61.98

1.95 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Monday
BAC

Bank of America

$29.77

1.235 (4.33%)

, DB

Deutsche Bank

$12.14

0.9 (8.01%)

16:33
07/16/18
07/16
16:33
07/16/18
16:33
General news
Fly Intel: Wall Street's top stories for Monday »

Stocks drifted throughout…

BAC

Bank of America

$29.77

1.235 (4.33%)

DB

Deutsche Bank

$12.14

0.9 (8.01%)

TRCO

Tribune Media

$32.05

-6.55 (-16.97%)

SBGI

Sinclair Broadcast

$29.10

-3.9 (-11.82%)

BHC

Bausch Health

$23.01

-0.39 (-1.67%)

VRX

Valeant

$0.00

(0.00%)

ARNC

Arconic

$19.19

1.8 (10.35%)

APO

Apollo Global

$35.90

-0.23 (-0.64%)

AMD

AMD

$16.58

0.305 (1.87%)

OSUR

OraSure

$16.28

-1.04 (-6.00%)

NTLA

Intellia Therapeutics

$29.37

-3.23 (-9.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 02

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Aug

  • 06

    Sep

CRSP

Crispr Therapeutics

$59.61

-6.13 (-9.32%)

14:01
07/16/18
07/16
14:01
07/16/18
14:01
Periodicals
Crispr Therapeutics tells CNBC does not use methods described in paper »

Crispr Therapeutics told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$59.09

-6.65 (-10.12%)

13:55
07/16/18
07/16
13:55
07/16/18
13:55
Options
Crispr Therapeutics put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

, NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

13:23
07/16/18
07/16
13:23
07/16/18
13:23
Periodicals
Editas tells CNBC 'not specifically concerned about' Crisper study »

Editas Medicine (EDIT)…

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$29.19

0.655 (2.30%)

, DB

Deutsche Bank

$12.10

0.86 (7.65%)

12:24
07/16/18
07/16
12:24
07/16/18
12:24
General news
Fly Intel: Wall Street's top stories at midday »

Stocks are little…

BAC

Bank of America

$29.19

0.655 (2.30%)

DB

Deutsche Bank

$12.10

0.86 (7.65%)

TRCO

Tribune Media

$33.06

-5.54 (-14.35%)

SBGI

Sinclair Broadcast

$31.35

-1.65 (-5.00%)

ARNC

Arconic

$19.23

1.84 (10.58%)

APO

Apollo Global

$35.90

-0.23 (-0.64%)

NVCR

Novocure

$35.20

2.1 (6.34%)

OSUR

OraSure

$16.23

-1.09 (-6.29%)

NTLA

Intellia Therapeutics

$30.58

-2.02 (-6.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 26

    Jul

  • 02

    Aug

  • 08

    Aug

  • 08

    Aug

  • 06

    Sep

CRSP

Crispr Therapeutics

$61.24

-4.5 (-6.85%)

, EDIT

Editas Medicine

$36.06

-1.85 (-4.88%)

11:17
07/16/18
07/16
11:17
07/16/18
11:17
Hot Stocks
Crisper names fall after study finds 'large deletions' in DNA breaks »

Shares of Crispr…

CRSP

Crispr Therapeutics

$61.24

-4.5 (-6.85%)

EDIT

Editas Medicine

$36.06

-1.85 (-4.88%)

NTLA

Intellia Therapeutics

$30.53

-2.07 (-6.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$64.77

-0.97 (-1.48%)

11:09
07/16/18
07/16
11:09
07/16/18
11:09
Periodicals
DNA damage from Crispr-CAS9 'seriously underestimated,' STATNews reports »

CRISPR-Cas9, a therapy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$64.92

-0.82 (-1.25%)

, EDIT

Editas Medicine

$37.59

-0.32 (-0.84%)

11:05
07/16/18
07/16
11:05
07/16/18
11:05
Hot Stocks
Breaking Hot Stocks news story on Crispr Therapeutics, Editas Medicine, Intellia Therapeutics »

Crispr, Editas, Intellia…

CRSP

Crispr Therapeutics

$64.92

-0.82 (-1.25%)

EDIT

Editas Medicine

$37.59

-0.32 (-0.84%)

NTLA

Intellia Therapeutics

$31.39

-1.21 (-3.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
CRSP

Crispr Therapeutics

$63.12

-0.98 (-1.53%)

11:35
06/27/18
06/27
11:35
06/27/18
11:35
Options
Crispr Therapeutics put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.